Market Currents
A recent FDA report cites serious flaws in St. Jude Medical's oversight of design changes made...
-
Tuesday, November 20, 2012, 7:35 PM ETA recent FDA report cites serious flaws in St. Jude Medical's oversight of design changes made to its Durata line of devices. Earlier this year, STJ had released a heavily redacted version of the FDA's report, but the recent release of the same report by the FDA shows highlights a pattern of inadequate verification and flawed testing procedures that could renew concerns over the safety of the Durata device. Shares -0.3% AH.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
